Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
Noosa News20 hours agoHeavy horsemen keep farming traditions alive
-
General13 hours agoCollingwood cult hero Mason Cox not offered new contract for 2026 AFL season
-
Noosa News17 hours agoSevere thunderstorms, damaging winds and large hail forecast for Saturday evening
-
Noosa News21 hours agoSouth East Queensland on alert as ‘right mix of ingredients’ could trigger severe storm outbreak